Robert Haeder
Optometrist · Sioux Falls, SDNPI 1922068873
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,000 of the $2,593 with a category attached, or 77.1%. Glaukos Corporation accounts for 81.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,159 and has fallen 87.0% since, to $151 in 2025. Among optometrist clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $92.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$2K
- Johnson & Johnson Vision Care, Inc.$175
- Coopervision Inc.$147
- Alcon$56
- Tarsus Pharmaceuticals, Inc.$35
- Shire North American Group Inc$25
- plus $52 from 3 others
What the payments were for
- Consulting fees$2,00077%
- Food & beverage$59323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 3 | $2,102 |
| Johnson & Johnson Vision Care, Inc. | 10 | $175 |
| Coopervision Inc. | 6 | $147 |
| Alcon | 3 | $56 |
| Tarsus Pharmaceuticals, Inc. | 2 | $35 |
| Shire North American Group Inc | 1 | $25 |
| Dompe US, Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
How this compares
$2,593 in reported general payments places this provider in the 90th percentile of 206 optometrist providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 15 | $18,270 |
| LumiganBimatoprost | 15 | $3,940 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 23 | $1,144 |
| Latanoprost | 89 | $1,108 |
| Prednisolone Acetate | 11 | $480 |
| MoxifloxacinMoxifloxacin Hcl | 13 | $278 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 16 | $141 |
| Timolol Maleate | 16 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $15 | $3,94015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 206 optometrist providers in South Dakota.
Other optometrist in Sioux Falls
- Justin SchweitzerSioux Falls$753K
- Mitchel IbachSioux Falls$395K
- Jason SchmitSioux Falls$79K
- Jeffery SaylerSioux Falls$8K
- Kayla KarpukSioux Falls$6K
- Travis LehrSioux Falls$5K
- Matthew ClarkeSioux Falls$5K
- Ryan HaiarSioux Falls$4K
- Kristen KramlichSioux Falls$4K
- Joshua TimsSioux Falls$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.